Nelfinavir Plasma Concentrations Are Low during Pregnancy
Open Access
- 1 September 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (5) , 736-740
- https://doi.org/10.1086/422719
Abstract
Plasma nelfinavir concentration ratios (CRs) were calculated for all pregnant (n = 27) and nonpregnant (n = 48) human immunodeficiency virus type 1—iKeywords
This publication has 17 references indexed in Scilit:
- Pharmacokinetics during pregnancy: evidence-based maternal dose formulationPublished by Wolters Kluwer Health ,2004
- Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant womenAIDS, 2003
- Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individualsAIDS, 2003
- Treatment Failure of Nelfinavir-Containing Triple Therapy Can Largely Be Explained by Low Nelfinavir Plasma ConcentrationsTherapeutic Drug Monitoring, 2003
- Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at deliveryJournal of Chromatography B, 2002
- Clinical Relevance of Therapeutic Drug Monitoring During PregnancyTherapeutic Drug Monitoring, 2002
- An argument for routine therapeutic drug monitoring of HIV-1 protease inhibitors during pregnancyAIDS, 2001
- Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- Plasma Protein Binding of Drugs in PregnancyClinical Pharmacokinetics, 1982